Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.

Connecticut medicine - 1 Apr 2007

Ruaño Gualberto, Blair C Lee, Bower Bruce, Windemuth Andreas, Kocherla Mohan, Aleman Yaraliz, Pearlson Godfrey, Goethe John W, Schwartz Harold I

Abstract excerpt

A 54-year-old woman presented with severe anxiety, multiple somatic complaints, medication intolerance and adverse drug reactions (ADRs) to numerous prescribed psychotropic medications. Multiple drug metabolizing deficiencies were suspected. Molecular analysis was performed for the CYP2 family of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 Enzyme System
Share to Headache
Share to Nausea

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Psychotropic Drugs

Share to Sequence Analysis, DNA

Share to Vomiting

Source

Identifiers

PMID: 17487003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17487003-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.PMID 17487003Read ↗

Complications of Psychotropic and Pain Medications in an Ultrarapid Metabolizer Patient at the Upper 1% of Cytochrome P450 (CYP450) Function Quantified by Combinatorial CYP450 Genotyping.Semantic proximity Read ↗

Pharmacogenetics and drug metabolism of newer antidepressant agents.Semantic proximity Read ↗

Interpreting and applying CYP450 genomic test results to psychotropic medications.Semantic proximity Read ↗

Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19Semantic proximity Read ↗

Pharmacogenomics Can Enhance Prescribing of Psychiatric Medications.Semantic proximity Read ↗

Pharmacogenomics and Individualized Drug TherapySemantic proximity Read ↗

Pharmacotherapy Associated with CYP2C19, CYP2C9, CYP2D6, and UGT1A1 Genes in Population Sample: Observational Cross Sectional Analytical StudySemantic proximity Read ↗

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.Semantic proximity Read ↗

CYP2D6 genotyping in patients on psychoactive drug therapy.Semantic proximity Read ↗

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.Semantic proximity Read ↗

Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.Semantic proximity Read ↗

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.